Current concepts in diastolic heart failure

Journal of the American Osteopathic Association

Volumn 108, Issue 4, 2008, Pages 203-209

  Dhar, Sunil ^a   Koul, Deepak ^a   D'Alonzo Jr , Gilbert E ^a  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE BESYLATE; CANDESARTAN; CANDESARTAN HEXETIL; DIGOXIN; VERAPAMIL;

CLINICAL TRIAL; CONCEPT ANALYSIS; DIASTOLIC HEART FAILURE; EARLY DIAGNOSIS; HEART MUSCLE ISCHEMIA; HUMAN; LUNG DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PATIENT CARE; PHYSICIAN; PRESSURE VOLUME CURVE; PRIMARY MEDICAL CARE; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SYSTOLIC HEART FAILURE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; CALCIUM CHANNEL BLOCKERS; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART FAILURE, DIASTOLIC; HUMANS;

EID: 43049120992     PISSN: 00986151     EISSN: 00986151     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Zile MR, Baicu CF, Bonnema DD. Diastolic heart failure: definitions and terminology. Prog Cardiovasc Dis. 2005;47:307-313.
2. Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT, et al. Systolic and diastolic heart failure in the community. JAMA. 2006;296:2209-2216.
3. Liao L, Jollis JG, Anstrom KJ, Whellan DJ, Kitzman DW, Aurigemma GP, et al. Costs for heart failure with normal vs reduced ejection fraction. Arch Intern Med. 2006;166:112-118. Available at: http://archinte.amaassn.org/cgi/ content/full/166/1/112. Accessed April 2, 2008.
4. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database [published correction appears in J Am Coll Cardiol. 2006;47:1502]. J Am Coll Cardiol. 2006;47:76-84.
5. Tsutsui H, Tsuchihashi M, Takeshita A. Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. Am J Cardiol. 2001;88:530-533.
6. Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 1998;98:2282-2289. Available at: http://circ.ahajournals.org/cgi/content/full/98/21/2282. Accessed April 2, 2008.
7. Kitzman DW, Gardin JM, Gottdiener JS, Arnold A, Boineau R, Aurigemma G, et al. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol. 2001;87:413-419.
8. MacCarthy PA, Kearney MT, Nolan J, Lee AJ, Prescott RJ, Shah AM, et al. Prognosis in heart failure with preserved left ventricular systolic function: prospective cohort study. BMJ. 2003;327:78-79. Available at: http://www.bmj.com/cgi/content/full/327/7406/78. Accessed April 2, 2008.
9. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 1999;33:1948-1955.
10. Aurigemma GP, Gottdiener JS, Shemanski L, Gardin J, Kitzman D. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study. J Am Coll Cardiol. 2001;37:1042-1048.
11. Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA. 2002;288:2144-2150. Available at: http://jama.ama-assn.org/cgi/content/full/288/ 17/2144. Accessed April 2, 2008.
12. Tardif JC, Rouleau JL. Diastolic dysfunction. Can J Cardiol. 1996;12:389-398.
13. Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure - abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med. 2004;350:1953-1959. Available at: http://content.nejm.org/cgi/content /abstract/350/19/1953. Accessed April 2, 2008.
14. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: part II. Causal mechanisms and treatment. Circulation. 2002;105:1503-1508. Available at: http://circ.ahajournals. org/cgi/content/full/105/12/1503. Accessed April 2, 2008.
15. Gandhi SK, Powers JC, Nomeir AM, Fowle K, Kitzman DW, Rankin KM, et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med. 2001;344:17-22. Available at: http://content.nejm.org/cgi/ content/abstract/344/1/17. Accessed April 2, 2008.
16. Kitzman DW, Higginbotham MB, Cobb FR, Sheikh KH, Sullivan MJ. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol. 1991;17:1065-1072.
17. Litwin SE, Grossman W. Diastolic dysfunction as a cause of heart failure. J Am Coll Cardiol. 1993;22(4 suppl A):49A-55A.
18. Apstein CS, Morgan JP. Cellular mechanism underlying left ventricular diastolic failure. In: Gaasch WH, Lewinter MM, eds. Left Ventricular Diastolic Dysfunction and Heart Failure. Philadelphia, Pa: Lea & Febiger; 1994:3-24.
19. Angeja BG, Grossman W. Evaluation and management of diastolic heart failure. Circulation. 2003;107:659-663. Available at: http://circ.ahajournals.org/cgi/reprint/107/5/659. Accessed April 3, 2008.
20. Froehlich JP, Lakatta EG, Beard E, Spurgeon HA, Weisfeldt ML, Gerstenblith G. Studies of sarcoplasmic reticulum function and contraction duration in young adult and aged rat myocardium. J Mol Cell Cardiol. 1978;10:427-438.
21. Tokushima T, Reid CL, Gardin JM. Left ventricular diastolic function in the elderly. Am J Geriatr Cardiol. 2001;10:20-29.
22. Maurer MS, Kronzon I, Burkhoff D. Ventricular pump function in heart failure with normal ejection fraction: insights from pressure-volume measurements. Prog Cardiovasc Dis. 2006;49:182-195.
23. Eberli FR, Strömer H, Ferrell MA, Varma N, Morgan JP, Neubauer S, et al. Lack of direct role for calcium in ischemic diastolic dysfunction in isolated hearts. Circulation. 2000;102:2643-2649. Available at: http://circ.ahajournals.org/cgi/content/full/102/21/2643. Accessed April 3, 2008.
24. Apstein CS, Grossman W. Opposite initial effects of supply and demand ischemia on left ventricular diastolic compliance: the ischemia-diastolic paradox. J Mol Cell Cardiol. 1987;19:119-128.
25. Varma N, Eberli FR, Apstein CS. Increased diastolic chamber stiffness during demand ischemia: response to quick length change differentiates rigor-activated from calcium-activated tension. Circulation. 2000;101:2185-2192. Available at: http://circ.ahajournals.org/cgi/content/full/ 101/18/2185. Accessed April 3, 2008.
26. Varma N, Eberli FR, Apstein CS. Left ventricular diastolic dysfunction during demand ischemia: rigor underlies increased stiffness without calcium-mediated tension. Amelioration by glycolytic substrate. J Am Coll Cardiol. 2001;37:2144-2153.
27. Zannad F, Dousset B, Alla F. Treatment of congestive heart failure: interfering the aldosterone-cardiac extracellular matrix relationship. Hypertension. 2001;38:1227-1232. Available at: http://hyper.ahajournals. org/cgi/content/full/38/5/1227. Accessed April 3, 2008.
28. Zhou G, Kandala JC, Tyagi SC, Katwa LC, Weber KT. Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts. Mol Cell Biochem. 1996;154:171-178.
29. Funck RC, Wilke A, Rupp H, Brilla CG. Regulation and role of myocardial collagen matrix remodeling in hypertensive heart disease. Adv Exp Med Biol. 1997;432:35-44.
30. Chua CC, Hamdy RC, Chua BH. Angiotensin II induces TIMP-1 production in rat heart endothelial cells. Biochim Biophys Acta. 1996;1311:175-180.
31. Pauschinger M, Knopf D, Petschauer S, Doerner A, Poller W, Schwimmbeck PL, et al. Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation. 1999;99:2750-2756. Available at: http://circ.ahajournals.org/cgi/content/full/99/21/2750. Accessed April 3, 2008.
32. Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol. 1994;26:809-820.
33. Guarda E, Katwa LC, Myers PR, Tyagi SC, Weber KT. Effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiovasc Res. 1993;27:2130-2134.
34. Barberá JA, Peinado VI, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J. 2003;21:892-905. Available at: http://erj.ersjournals.com/cgi/content/full/21/5/892. Accessed April 3, 2008.
35. Baum GL, Schwartz A, Llamas R, Castillo C. Left ventricular function in chronic obstructive lung disease. N Engl J Med. 1971;285:361-365.
36. Braunwald E, Zipes DP, Libby P. Heart Disease: A Textbook of Cardiovascular Medicine. 6th ed. Philadelphia, Pa: W.B. Saunders; 2001.
37. Schena M, Clini E, Errera D, Quadri A. Echo-Doppler evaluation of left ventricular impairment in chronic cor pulmonale. Chest. 1996;109:1446-1451. Available at: http://www.chestjournal.org/cgi/reprint/109/6/ 1446. Accessed April 3, 2008.
38. Gomez A, Mink S. Increased left ventricular stiffness impairs filling in dogs with pulmonary emphysema in respiratory failure. J Clin Invest. 1986;78:228-240. Available at: http://www.jci.org/articles/view/112556/pdf. Accessed April 3, 2008.
39. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96:1897-1904. Available at: http://www.jci.org/articles/view/118235/pdf. Accessed April 3, 2008.
40. Bradley TD, Hall MJ, Ando S, Floras JS. Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure. Chest. 2001;119:1827-1835. Available at: http://www.chestjournal.org/cgi /content/ full/119/6/1827. Accessed April 3, 2008.
41. Arai M, Alpert NR, MacLennan DH, Barton P, Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res. 1993;72:463-469.
42. Gaasch WH, Blaustein AS, Andrias CW, Donahue RP, Avitall B. Myocardial relaxation. II. Hemodynamic determinants of rate of left ventricular isovolumic pressure decline. Am J Physiol. 1980;239:H1-H6.
43. Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation. 2000;102:470-479. Available at: http://circ.ahajournals.org/cgi/content/full/102/4/470. Accessed April 3, 2008.
44. Virolainen J, Ventilä M, Turto H, Kupari M. Effect of negative intrathoracic pressure on left ventricular pressure dynamics and relaxation. J Appl Physiol. 1995;79:455-460.
45. Brinker JA, Weiss JL, Lappé DL, Rabson JL, Summer WR, Permutt S, et al. Leftward septal displacement during right ventricular loading in man. Circulation. 1980;61:626-633.
46. Arias MA, García-Río F, Alonso-Fernández A, Mediano O, Martínez I, Villamor J. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation. 2005;112:375-383. Available at: http://circ.ahajournals.org/cgi/content/full/112/3/375. Accessed April 3, 2008.
47. Maurer MS, King DL, El-Khoury Rumbarger L, Packer M, Burkhoff D. Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms. J Card Fail. 2005;11:177-187.
48. How to diagnose diastolic heart failure. European Study Group on Diastolic Heart Failure. Eur Heart J. 1998;19:990-1003. Available at: http://eur heartj.oxfordjournals.org/cgi/reprint/19/7/990. Accessed April 3, 2008.
49. Vasan RS, Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation. 2000;101:2118-2121. Available at: http://circ.ahajournals.org/cgi/content/full/101/17/2118. Accessed April 3, 2008.
50. Smith GL, Masoudi FA, Vaccarino V, Radford MJ, Krumholz HM. Outcomes in heart failure patients with preserved ejection fraction: mortality, re-admission, and functional decline. J Am Coll Cardiol. 2003;41:1510-1518.
51. Cohen GI, Pietrolungo JF, Thomas JD, Klein AL. A practical guide to assessment of ventricular diastolic function using Doppler echocardiography. J Am Coll Cardiol. 1996;27:1753-1760.
52. Garcia M, Smedira N, Greenberg NL, Wong J, Zhou J, Rodriguez L, et al. Transmitral early deceleration time predicts LV pressure changes: implications for the non-invasive estimation of LV stiffness [abstract]. J Am Coll Cardiol. 1998;31:163A.
53. Garcia MJ, Thomas JD, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol. 1998;32:865-875.
54. Rakowski H, Appleton C, Chan KL, Dumesnil JG, Honos G, Jue J, et al. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr. 1996;9:736-760.
55. Setaro JF, Zaret BL, Schulman DS, Black HR, Soufer R. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol. 1990;66:981-986.
56. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, et al; CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003;362:777-781.
57. Schnieder RE, Messerli FH, Garavaglia GE, Nunez BD. Cardiovascular effects of verapamil in patients with essential hypertension. Circulation. 1987;75:1030-1036.
58. Amodeo C, Kobrin I, Ventura HO, Messerli FH, Frohlich ED. Immediate and short-term hemodynamic effects of diltiazem in patients with hypertension. Circulation. 1986;73:108-113.
59. Nishikawa N, Masuyama T, Yamamoto K, Sakata Y, Mano T, Miwa T, et al. Long-term administration of amlodipine prevents decompensation to diastolic heart failure in hypertensive rats. J Am Coll Cardiol. 2001;38:1539-1545.
60. Mottram PM, Haluska B, Leano R, Cowley D, Stowasser M, Marwick TH. Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Circulation. 2004;110:558-565. Available at: http://circ.ahajournals.org/cgi/content/full/110/5/558. Accessed April 3, 2008.
61. Thohan V, Torre-Amione G, Koerner MM. Aldosterone antagonism and congestive heart failure: a new look at an old therapy. Curr Opin Cardiol. 2004;19:301-308.
62. Buss SJ, Backs J, Kreusser MM, Hardt SE, Maser-Gluth C, Katus HA, et al. Spironolactone preserves cardiac norepinephrine reuptake in salt-sensitive Dahl rats. Endocrinology. 2006;147:2526-2534. Available at: http://endo.endojournals.org/cgi/content/full/147/5/2526. Accessed April 16, 2008.
63. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med. 1997;336:525-533.
64. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154-e235. Available at: http://circ.ahajournals.org/cgi/content/full/112/12/e154. Accessed April 3, 2008.
65. Larsen KO, Sjaastad I, Svindland A, Krobert KA, Skjønsberg OH, Christensen G. Alveolar hypoxia induces left ventricular diastolic dysfunction and reduces phosphorylation of phospholamban in mice. Am J Physiol Heart Circ Physiol. 2006;291:H507-H516. Available at: http://ajpheart.physiology.org/ cgi/content/full/291/2/H507. Accessed April 16, 2008.
66. Little WC, Zile MR, Kitzman DW, Hundley WG, O'Brien TX, Degroof RC. The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure. J Card Fail. 2005;11:191-195.
67. Cohn JN, Johnson G. Heart failure with normal ejection fraction. The V-HeFT Study. Veterans Administration Cooperative Study Group. Circulation. 1990;81(suppl 2):III48-III53.
68. Mathew ST, Gottdiener JS, Kitzman D, Aurigemma G. Congestive heart failure in the elderly: the Cardiovascular Health Study. Am J Geriatr Cardiol. 2004;13:61-68.
69. Rich MW, McSherry F, Williford WO, Yusuf S; Digitalis Investigation Group. Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study. J Am Coll Cardiol. 2001;38:806-813.
70. Owan TE, Redfield MM. Epidemiology of diastolic heart failure. Prog Cardiovasc Dis. 2005;47:320-332.